Company Filing History:
Years Active: 2019
Title: **Innovative Breakthroughs by Inventor Chieh-Hung Lin**
Introduction
Chieh-Hung Lin is a prominent inventor based in Tainan, Taiwan, known for his significant contributions to the field of biotechnology. With a keen focus on addressing health issues, particularly hyperglycemia and diabetes mellitus, Lin has demonstrated a commitment to innovation and research that holds promise for improving patient outcomes.
Latest Patents
Chieh-Hung Lin holds a notable patent titled "Use of a polysaccharide mixture for treating hyperglycemia". This invention discloses a novel application of a polysaccharide mixture that comprises approximately 30-50% (wt %) of β(1→3) glucan and β(1→6) glucan, with a molecular weight of at least 500,000. The polysaccharide mixture is designed to be administered to individuals suffering from hyperglycemia in doses ranging from about 1 to 1,000 mg/Kg, aiming to ameliorate symptoms associated with hyperglycemia and related disorders.
Career Highlights
Chieh-Hung Lin is currently affiliated with Trineo Biotechnology Co., Ltd., where he continues to push the boundaries of scientific research and application. His focus on harnessing natural compounds for therapeutic uses highlights his innovative approach to solving pressing health concerns.
Collaborations
Throughout his career, Lin has collaborated with talented colleagues such as Cheng-Po Huang and Cheng-Chiu Tsao, enhancing research efforts and fostering a collaborative environment for innovation at Trineo Biotechnology Co., Ltd. These partnerships underscore the importance of teamwork in the realm of scientific discovery and patent development.
Conclusion
Chieh-Hung Lin's advancements in the biotechnological field, particularly through his patent on polysaccharide mixtures for treating hyperglycemia, reflect his dedication to innovation in healthcare. As he continues to work alongside skilled professionals, Lin exemplifies the spirit of invention that drives progress in addressing societal health issues. His contributions pave the way for potential breakthroughs that could greatly benefit individuals dealing with hyperglycemia and similar disorders.